Early research (Phase 1)Study completedNCT04095273
What this trial is testing
Study to Test How Well Patients With Advanced Solid Tumors Respond to Treatment With the Elimusertib in Combination With Pembrolizumab, to Find the Optimal Dose for Patients, How the Drug is Tolerated and the Way the Body Absorbs, Distributes and Discharges the Drug
Who this might be right for
Advanced Solid Tumors
Bayer 56